Sign in

Trial result ·

Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism: A Randomized Clinical Trial.

Written based on 1 research study on PubMed, searched on 5 Nov 2026.

What was studied

This trial tested testosterone in men who once had prostate cancer. All had their prostate taken out by surgery. Their cancer was low grade and had stayed inside the prostate. They had low testosterone and signs like low sex drive or feeling tired. Men got a weekly shot of testosterone or a dummy shot for 12 weeks. Chance decided the group, and no one knew who got what. It was a phase 2 trial at 2 medical centers.

What they found

A total of 136 men took part, with 68 in each group. Of these, 125 men finished the study. No man in either group had biochemical recurrence. This was defined as a PSA of 0.2 ng/mL or more. Men on testosterone had more sex than men on the dummy shot. They also had more sex drive and fewer bad feelings. Erection function did not change. Body build, stair climbing power and fitness got better with testosterone.

What it means for patients

The authors say 12 weeks of testosterone improved sex life, well-being, body and fitness. In this short trial, no man had biochemical recurrence. They say this early trial gives a reason for a larger, longer study. The results do not apply to men with high-grade cancer. They also do not apply to men treated with hormone-blocking drugs or with radiation.

Why it is not certain yet

The trial lasted only 12 weeks. The authors say it was too short and too small to judge long-term safety. It could not tell if the cancer might come back later in the body. It only included men with low-grade cancer after surgery. This was an early trial, so a bigger study is still needed.

The registered trial

The paper names this trial from a public trial registry. Its page shows who the trial is for, its sites and its status.

Source

Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism: A Randomized Clinical Trial.

PubMed · PMID 42113507

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Prostate cancer publications